|Gallo: FLSC Phase I & II Clinical Trials
|Protein & peptide vaccines
|Study Start Date:
|Study Made Public:
Investigation study into the immunogencity of various adjuvants in pursuit of a FLSC HIV vaccine
CAVD 392 is a non-human primate study to evaluate and compare the immunogenicity of different adjuvants in combination with the immunogen, rhFLSC.
Sign in to see full information about this study and to download study data.